Discovery of leukotrienes and development of antileukotriene agents (Q34293766)

1 August 2017

1 reference

title

Discovery of leukotrienes and development of antileukotriene agents (English)

1 reference

1 August 2017

A R Leff

1

1 reference

1 August 2017

Antileukotriene Working Group

series ordinal

2

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Annals of Allergy, Asthma & Immunology

1 August 2017

published in

1 reference

1 August 2017

volume

86

1 reference

1 August 2017

issue

6 Suppl 1

1 reference

1 August 2017

page(s)

4-8

1 reference

Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Slow-reacting substance of anaphylaxis Purification and characterisation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Structure of leukotriene C identification of the amino acid part

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Stereochemistry of leukotriene C-1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Leukotriene D: a slow reacting substance from rat basophilic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

The inhibitory effects of BW 755C on arachidonic acid metabolism in human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Nomenclature for leukotrienes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Involvement of calcium in the thimerosal-stimulated formation of leukotriene by fMLP in human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Studies on the activation of human neutrophil 5-lipoxygenase induced by natural agonists and Ca2+ ionophore A23187

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

1 reference

7 January 2021

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Molecular cloning and expression of human leukotriene-C4 synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Formation and actions of leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Leukotrienes as therapeutic target in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Leukotriene B: a potential mediator of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

A novel leukotriene antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962305-8

7 January 2021

10.1016/S1081-1206(10)62305-8

Identifiers

DOI

1 reference

1 August 2017

1 reference